Home

WILLIAM MCKEE

CIK 1237262 · Chief Financial Officer · last filed 2026-06-16

WILLIAM MCKEE is a Chief Financial Officer who has filed 48 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for ASRT, was dated Jun 16, 2026. Across all open-market trades the lifetime net is −$763.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $20.4K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$20.4K

Companies

8

Total Filings

48

Lifetime Open-Market Net

-$763.1K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Assertio Holdings, Inc. (ASRT) Delisted Director 0 $23.50 $0 -$220.9K 13 2026-06-16
Rein Therapeutics, Inc. (ALRN) Delisted Director — $2.11 — $0 4 2022-06-17
CCCC Chief Financial Officer 5,263 $3.87 $20.4K $100.0K 1 2020-10-06
AGILE THERAPEUTICS INC (AGRX) Delisted Director 9 $1.51 $14 $0 5 2019-06-07
Assertio Therapeutics, Inc (DEPO) Delisted Director — — — $0 3 2018-05-10
Dare Bioscience, Inc. (CERU) Delisted Director 342 — — $0 4 2017-01-05
AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted Director 0 — — -$642.2K 9 2015-01-30
BARR PHARMACEUTICALS INC (BRL) Delisted EVP, CFO 8,977 — — $0 7 2008-12-19

Recent Filings

48 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-16 Assertio Holdings, Inc. (ASRT) Delisted Mixed −27,936 $0 EDGAR
2026-05-06 Assertio Holdings, Inc. (ASRT) Delisted Grant (A) +4,851 $0 EDGAR
2025-05-09 Assertio Holdings, Inc. (ASRT) Delisted Grant (A) +53,750 $0 EDGAR
2024-05-28 Assertio Holdings, Inc. (ASRT) Delisted Grant (A) +53,750 $0 EDGAR
2023-08-15 Assertio Holdings, Inc. (ASRT) Delisted Sell (S) −22,000 -$69.0K EDGAR
2023-08-14 Assertio Holdings, Inc. (ASRT) Delisted Notice (144) −22,000 -$69.0K EDGAR
2023-05-12 Assertio Holdings, Inc. (ASRT) Delisted Grant (A) +31,194 $0 EDGAR
2022-06-17 Rein Therapeutics, Inc. (ALRN) Delisted Grant (A) — $0 EDGAR
2022-05-16 Assertio Holdings, Inc. (ASRT) Delisted Sell (S) −22,322 -$52.5K EDGAR
2022-05-06 Assertio Holdings, Inc. (ASRT) Delisted Grant (A) +86,286 $0 EDGAR
Showing 1–10 of 48
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.